磷酸化碱性成纤维细胞生长因子受体1抗体

Quantity size:

0.1ml

Concentration:

1mg/ml 磷酸化碱性成纤维细胞生长因子受体1抗体  Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

Fibroblast growth factors (FGFs) produce mitogenic and angiogenic effects in target cells by signaling through the cellular surface tyrosine kinase receptors. There are four members of the FGF receptor family: FGFR-1 (flg), FGFR-2 (bek, KGFR), FGFR-3 and FGFR-4. Each receptor contains an extracellular ligand binding domain, a transmembrane region and a cytoplasmic kinase domain (1). Following ligand binding and dimerization, the receptors磷酸化碱性成纤维细胞生长因子受体1抗体 are phosphorylated at specific tyrosine residues (2). Seven tyrosine residues in the cytoplasmic tail of FGFR-1 can be phosphorylated: Tyr463, Tyr583, Tyr585, Tyr653, Tyr654, Tyr730 and Tyr766. Tyrosine 653 and 654 are important for catalytic activity of the activated FGFR and are essential for signaling (3). The other phosphorylated tyrosine residues may provide docking sites for downstream signaling components such as Crk and PLCgamma.

磷酸化碱性成纤维细胞生长因子受体1抗体Also known as:

FGFR1 alpha (phospho Y654) ; FGFR1 (phospho Y653 + Y654); p-FGFR1 (phospho Y653 + Y654); bFGF R; BFGFR; C FGR; CD 331; CD331; CD331 antigen; FGF Receptor; CEK; FGFBR; FGFR 1; Fibroblast growth factor receptor 1; FLG; FLG protein; FLJ14326; FLT 2; FLT2; Fms like tyrosine kinase 2; Fms related tyrosine kinase 2; Fms related tyrosine kinase 2 Pfeiffer syndrome;磷酸化碱性成纤维细胞生长因子受体1抗体 H2; H3; H4; H5; HBGFR; Heparin binding growth factor receptor; Hydroxyaryl protein kinase; KAL 2; KAL2; MFR; N SAM; N sam tyrosine kinase; Protein tyrosine kinase; Tyrosylprotein kinase; Basic fibroblast growth factor receptor 1.

Specificity:

●

Rabbit Polyclonal IgG, affinity purified by Protein A.

●

Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, .

●

Immunogen: KLH conjugated Synthesised phosphopeptide derived from human.

●

Predicted Molecular Weight: 88kDa.

磷酸化碱性成纤维细胞生长因子受体1抗体Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  ICC=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl040Mu01围脂滴蛋白4(PLIN4)多克隆抗体Polyclonal Antibody to Perilipin 4 (PLIN4)

kl041Hu01围脂滴蛋白3(PLIN3)多克隆抗体Polyclonal Antibody to Perilipin 3 (PLIN3)

kl045Ra01大麻素受体2(CNR2)多克隆抗体Polyclonal Antibody to Cannabinoid Receptor 2, Macrophage (CNR2)

kl047Hu01原钙黏素γA2(PCDHγA2)多克隆抗体Polyclonal Antibody to Protocadherin Gamma A2 (PCDHgA2)

kl072Hu01原钙黏素β16(PCDHβ16)多克隆抗体Polyclonal Antibody to Protocadherin Beta 16 (PCDHb16)

kl095Hu01原钙黏素15(PCDH15)多克隆抗体Polyclonal Antibody to Protocadherin 15 (PCDH15)

kl095Mu01原钙黏素15(PCDH15)多克隆抗体Polyclonal Antibody to Protocadherin 15 (PCDH15)

kl107Hu01肝配蛋白A1(EFNA1)多克隆抗体Polyclonal Antibody to Ephrin A1 (EFNA1)

kl109Hu01肝配蛋白A3(EFNA3)多克隆抗体Polyclonal Antibody to Ephrin A3 (EFNA3)

kl110Hu01肝配蛋白A4(EFNA4)多克隆抗体Polyclonal Antibody to Ephrin A4 (EFNA4)

kl111Hu01肝配蛋白A5(EFNA5)多克隆抗体Polyclonal Antibody to Ephrin A5 (EFNA5)

kl112Hu01肝配蛋白B2(EFNB2)多克隆抗体Polyclonal Antibody to Ephrin B2 (EFNB2)

kl112Mu01肝配蛋白B2(EFNB2)多克隆抗体Polyclonal Antibody to Ephrin B2 (EFNB2)

kl118Mu01肝配蛋白B受体3(EPHB3)多克隆抗体Polyclonal Antibody to Ephrin Type B Receptor 3 (EPHB3)

kl118Ra01肝配蛋白B受体3(EPHB3)多克隆抗体Polyclonal Antibody to Ephrin Type B Receptor 3 (EPHB3)

kl122Hu01肝配蛋白A受体10(EPHA10)多克隆抗体Polyclonal Antibody to Ephrin Type A Receptor 10 (EPHA10)

kl131Hu01乳酸脱氢酶C(LDHC)多克隆抗体Polyclonal Antibody to Lactate Dehydrogenase C (LDHC)

kl134Hu01防御素α6(DEFα6)多克隆抗体Polyclonal Antibody to Defensin Alpha 6, kleth Cell Specific (DEFa6)

kl135Hu01防御素α3(DEFα3)多克隆抗体Polyclonal Antibody to Defensin Alpha 3, Neutrophil Specific (DEFa3)

kl140Hu01γ-谷氨酰基转氨酶5(γGT5)多克隆抗体Polyclonal Antibody to Gamma-Glutamyltransferase 5 (gGT5)

kl144Hu01脂质运载蛋白9(LCN9)多克隆抗体Polyclonal Antibody to Lipocalin 9 (LCN9)

kl149Mu01母系蛋白2(MATN2)多克隆抗体Polyclonal Antibody to Matrilin 2 (MATN2)

kl158Hu01Saitohin蛋白(STH)多克隆抗体Polyclonal Antibody to Saitohin (STH)